Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-03-25 4:28 pm Purchase | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 2,070,544 9.99% | 82,842 (+4.17%) | View |
2024-02-14 4:47 pm Purchase | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | PAULSON & CO. INC. | 1,105,741 5.6% | 105,741 (+10.57%) | View |
2024-02-14 2:50 pm Sale | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | ARMISTICE CAPITAL LLC | 50,000 0.25% | -158,000 (-75.96%) | View |
2024-02-14 09:21 am Purchase | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | Avoro Capital Advisors LLC | 2,288,888 9.9% | 628,888 (+37.88%) | View |
2024-02-13 5:55 pm Sale | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | JANUS HENDERSON GROUP PLC JHG | 2,902,050 14.7% | -140,611 (-4.62%) | View |
2024-02-13 5:08 pm Purchase | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | VANGUARD GROUP INC | 1,574,742 7.98% | 308,367 (+24.35%) | View |
2024-01-29 5:25 pm Purchase | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | BlackRock Inc. BLK | 1,212,562 6.1% | 225,990 (+22.91%) | View |
2024-01-22 11:13 am Sale | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | STATE STREET CORP STT | 700,739 3.55% | -560,254 (-44.43%) | View |
2023-12-13 4:05 pm Sale | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | BAY CITY CAPITAL LLC | 567,644 2.9% | -1,469,496 (-72.14%) | View |
2023-11-21 5:24 pm Sale | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 1,987,702 9.99% | -28,058 (-1.39%) | View |
2023-11-13 4:39 pm Purchase | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | PAULSON & CO. INC. | 1,000,000 5.1% | 1,000,000 (New Position) | View |
2023-10-10 1:05 pm Purchase | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | JANUS HENDERSON GROUP PLC JHG | 3,042,661 15.4% | 1,132,360 (+59.28%) | View |
2023-10-05 4:36 pm Purchase | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 2,015,760 9.99% | 470,647 (+30.46%) | View |
2023-09-08 4:36 pm Purchase | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | JANUS HENDERSON GROUP PLC JHG | 1,910,301 10.3% | 1,910,301 (New Position) | View |
2023-08-08 5:16 pm Unchanged | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 1,545,113 8.4% | 0 (Unchanged) | View |
2023-06-16 7:18 pm Unchanged | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 1,545,113 8.4% | 0 (Unchanged) | View |
2023-02-14 4:00 pm Purchase | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 1,545,113 9% | 45,900 (+3.06%) | View |
2023-02-14 1:05 pm Sale | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | ARMISTICE CAPITAL LLC | 208,000 1.21% | -916,000 (-81.49%) | View |
2023-02-14 09:37 am Purchase | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | Avoro Capital Advisors LLC | 1,660,000 9.7% | 235,000 (+16.49%) | View |
2023-02-14 08:45 am Sale | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | Deep Track Capital LP | 0 0% | -917,825 (Position Closed) | View |